Trial Profile
Therapeutic Effects of BNP in Hypertensive Patients
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Nesiritide (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- Acronyms TENSE 1
- 04 Sep 2021 This trial has been discontinued in Norway, according to European Clinical Trials Database.
- 25 Nov 2016 New trial record